Thursday, September 18, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

NuScale Power Stock Gains Momentum with Major Nuclear Partnership

Robert Sasse by Robert Sasse
September 15, 2025
in Analysis, Energy & Oil, Mergers & Acquisitions
0
Nuscale Power Stock
0
SHARES
26
VIEWS
Share on FacebookShare on Twitter

NuScale Power shares demonstrated notable strength last week, posting gains exceeding 5%. This upward trajectory is largely attributed to the market’s continued positive reception of the company’s landmark 6-gigawatt collaborative agreement with ENTRA1 Energy and the Tennessee Valley Authority (TVA).

Strategic Partnership Fuels Market Confidence

The substantial partnership is centered on the deployment of up to 6 GW of NRC-certified small modular reactor (SMR) capacity throughout the TVA’s service territory. This initiative is designed to supply carbon-free baseload power to meet America’s escalating energy demands, specifically catering to high-consumption sectors such as artificial intelligence, hyperscale data centers, and semiconductor manufacturing.

Market experts have responded favorably to these developments. In early September, both Canaccord Genuity and Bank of America raised their price targets for NuScale Power. UBS followed by increasing its own target from $34 to $38 per share. The consensus average price objective now resides in a range between $36.20 and $38.33.

Should investors sell immediately? Or is it worth buying Nuscale Power?

A Distinct Competitive Edge

A key factor driving optimism is NuScale’s unique standing as the sole SMR technology provider with designs already certified by the Nuclear Regulatory Commission. This critical regulatory milestone significantly bolsters the technology’s credibility and readiness for deployment. The current surge in demand for dependable, clean energy sources positions the company at the forefront of a transforming energy sector.

Looking ahead, the focus turns to execution. CEO John Hopkins has outlined ambitious objectives, stating that NuScale aims to secure “firm contracts” with two or three major U.S. utility customers by the end of 2025. The momentum generated by the TVA alliance, coupled with expanding interest from multiple industries, provides a solid foundation for achieving this goal.

Closing the week at $36.34, NuScale’s stock price is now trading within the range of many analyst projections. The company’s upcoming quarterly results, scheduled for November 6th, will be a crucial indicator of its progress in transitioning from research and development to full-scale commercial implementation.

Ad

Nuscale Power Stock: Buy or Sell?! New Nuscale Power Analysis from September 18 delivers the answer:

The latest Nuscale Power figures speak for themselves: Urgent action needed for Nuscale Power investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from September 18.

Nuscale Power: Buy or sell? Read more here...

Tags: Nuscale Power
Robert Sasse

Robert Sasse

About Dr. Robert Sasse Accomplished economist, entrepreneur, and profound expert in financial markets. Dr. Robert Sasse holds a doctorate in economics and combines academic rigor with practical entrepreneurial experience. His deep expertise in economic relationships and unwavering conviction for a free-market liberal economic order drives his mission to provide investors with well-founded knowledge and guidance.
Areas of Expertise:
  • Economic Theory and Practice
  • Free-Market Economics
  • Entrepreneurship and Business Strategy
  • Investment Philosophy
Dr. Sasse's unique combination of academic knowledge and real-world business experience enables him to provide investors with comprehensive insights that bridge theory and practice.

Related Posts

Eli Lilly Stock
Analysis

Eli Lilly’s Oral Diabetes Candidate Outperforms Rival in Clinical Showdown

September 18, 2025
Broadcom Stock
AI & Quantum Computing

Broadcom’s $10 Billion Mystery Client Fuels AI Growth Surge

September 18, 2025
Adobe Stock
AI & Quantum Computing

Adobe’s AI Breakthrough Fails to Impress Investors

September 18, 2025
Next Post
Gartner Stock

Can Gartner's Massive Share Buyback Reverse Its Stock Decline?

Incyte Stock

Incyte Investors Await Pivotal FDA Ruling on Dermatology Drug

MP Materials Stock

MP Materials Navigates Strategic Gains Amid Financial Headwinds

Recommended

Consumer Electronics Stock Bull Market

Analysts Bullish on BellRing Brands with Increased Price Target

2 years ago
Technology Cloud computing Trading online

DWAC and TMTG Move Closer to Merger A Milestone in the Creation of Truth Social

2 years ago
Finance_ Investing in stocks

Citi Launches 30Day Downside Catalyst Watch on PayPal

2 years ago

Wedbush Analyst Upgrades Jack In The Box to Outperform

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

AAPL Adobe Alibaba Alphabet Amazon AMD AMZN Apple ASML BA BigBear.ai BioNTech Broadcom Coinbase DIS Eli Lilly Fiserv IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Nvidia Opendoor Oracle Oxford Lane Capital Palantir Red Cat Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Tesla Tilray TSLA Unitedhealth Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Boeing’s Dual Challenge: Innovation Gains Amid Regulatory Setbacks

Yum China Doubles Down on Shareholder Returns Amid Market Volatility

Can a Strategic Alliance Reverse Alight’s Downward Trajectory?

Caterpillar Stock: Record Run Faces Mounting Headwinds

Quest Diagnostics Emerges as a Quiet Powerhouse in Healthcare Innovation

Monte Rosa Therapeutics Shares Surge on Major Novartis Partnership Expansion

Trending

Eli Lilly Stock
Analysis

Eli Lilly’s Oral Diabetes Candidate Outperforms Rival in Clinical Showdown

by Felix Baarz
September 18, 2025
0

Eli Lilly has delivered a decisive victory in a head-to-head clinical trial against competitor Novo Nordisk, with...

Broadcom Stock

Broadcom’s $10 Billion Mystery Client Fuels AI Growth Surge

September 18, 2025
Adobe Stock

Adobe’s AI Breakthrough Fails to Impress Investors

September 18, 2025
Boeing Stock

Boeing’s Dual Challenge: Innovation Gains Amid Regulatory Setbacks

September 18, 2025
Yum China Stock

Yum China Doubles Down on Shareholder Returns Amid Market Volatility

September 18, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Eli Lilly’s Oral Diabetes Candidate Outperforms Rival in Clinical Showdown
  • Broadcom’s $10 Billion Mystery Client Fuels AI Growth Surge
  • Adobe’s AI Breakthrough Fails to Impress Investors

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com